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https://doi.org/10.1016/j.celrep.2020.108150SUMMARYHerpes simplex virus (HSV)-1 encephalitis has significant morbidity partly because of an over-exuberant im-
mune response characterized by leukocyte infiltration into the brain and increased blood-brain barrier (BBB)
permeability. Determining the role of specific leukocyte subsets and the factors that mediate their recruit-
ment into the brain is critical to developing targeted immune therapies. In a murine model, we find that the
chemokines CXCL1 and CCL2 are induced in the brain following HSV-1 infection. Ccr2 (CCL2 receptor)-defi-
cient mice have reducedmonocyte recruitment, uncontrolled viral replication, and increasedmorbidity. Con-
trastingly, Cxcr2 (CXCL1 receptor)-deficient mice exhibit markedly reduced neutrophil recruitment, BBB
permeability, and morbidity, without influencing viral load. CXCL1 is produced by astrocytes in response
to HSV-1 and by astrocytes and neurons in response to IL-1a, and it is the critical ligand required for neutro-
phil transendothelial migration, which correlates with BBB breakdown. Thus, the CXCL1-CXCR2 axis repre-
sents an attractive therapeutic target to limit neutrophil-mediated morbidity in HSV-1 encephalitis.INTRODUCTION
Viral encephalitis, which most commonly results from herpes sim-
plex virus type 1 (HSV-1), is characterized by the earlymigration of
neutrophils and monocytes into the brain, forming perivascular
cuffs and increased blood-brain barrier (BBB) permeability (Ma-
santi and Weller, 2004). Despite treatment with the nucleoside
analog acyclovir, there is marked cerebral edema; furthermore,
10%–20% of patients die, and most survivors have significant
neurological sequelae (Venkatesan et al., 2019). Biomarkers of
BBB permeability and cerebral edema, visualized by brain imag-
ing, correlate with a poor outcome and with inflammatory cyto-
kines and chemokines relating to interleukin (IL)-1a and IL-1b in
the cerebrospinal fluid (CSF) of patients with viral encephalitis
(Michael etal., 2016b).Elevated levelsofmyeloperoxidase, reflect-
ing neutrophil numbers and degranulation, are also found in the
CSF (Michael etal., 2016a), andprolongeddetectionofneutrophils
in the CSF correlates with CSF CXCL1 concentration and neuro-
logical sequelae (Grygorczuk et al., 2018). Inmurinemodels, intra-
cranial (i.c.) injection of IL-1b is associated with neutrophil migra-Cel
This is an open access article under the CC BY-Ntion into the brain and impairment of BBB integrity, although the
exact underlying mechanisms remain to be elucidated (Bolton
et al., 1998). In particular, the predominant neuroglia responsible
for production of the principal cytokines and chemokines that
leads to neutrophil recruitment, retention as perivascular cuffs,
and consequent breakdown of the BBB are poorly understood.
In an attempt to reduce cerebral edema, corticosteroids are
sometimes given. However, because of their broad immunosup-
pressive effects, there is concern that this may license increased
viral replication, and it is unclearwhetheronbalance theyarebene-
ficial (Meyding-Lamade´ et al., 2003; Solomon et al., 2012). An
improved understanding of the biological mechanisms driving
the migration of specific leukocyte populations into the brain and
breakdown of the BBB are required to develop targeted immuno-
therapies to reducethe transmigrationofprecisedeleterious leuko-
cyte populations and maintain the integrity of the BBB without
risking uncontrolled viral replication (Venkatesan et al., 2019).
Intravital microscopy studies of i.c. infection with HSV-1
demonstrate increased leukocyte rolling and adhesion in
association with upregulation of multiple chemokines, but thel Reports 32, 108150, September 15, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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chemokine receptor-ligand interactions, and the pivotal stages of
transmigration affecting on BBB permeability have not been
elucidated (Vilela et al., 2008). It has been found that i.c. infection
with the non-cytopathic lymphocytic choriomeningitis virus
(LCMV) is associated with marked myeloid cell infiltration and
breakdown of the BBB (Kim et al., 2009). In thismodel, abrogation
of monocyte recruitment using Ccr2/ mice does not alter
mortality. However, depletion of both monocytes and neutrophils
using a combination of Ccr2/ mice treated with aGr1 antibody
results in reduced mortality (Kim et al., 2009). Similarly reduced
hippocampal injury in response to picornavirus infection has
been reported following inhibition of monocyte and neutrophil
recruitment (Howe et al., 2012). Conversely, i.c. infection with
HSV-1,which is cytopathic, is associatedwith increasedmortality
when animals are deficient in monocyte cell recruitment, i.e.,
when using an aCCL2 antibody or Ccr2/ mice (Boivin et al.,
2012; Conrady et al., 2013; Menasria et al., 2016). This discrep-
ancy in the role of myeloid cell infiltration in different brain infec-
tions warrants further investigation so that directed treatment
can be developed. In addition, although the role of chemokines
in modulating intravascular leukocyte dynamics is frequently
studied, the role of these ligands following transendothelialmigra-
tion is less well understood (Kim et al., 2009; Teixeira et al., 2010;
Vilela et al., 2010, 2013). Even though astrocytes are recognized
to play a pivotal role in the maintenance of tight junctions and ad-
herens junctions of cerebral capillaries and post-capillary venules
that form the BBB, their role in inducing leukocyte migration and
BBB permeability in viral encephalitis have not been fully eluci-
dated (Klein and Hunter, 2017).
We report that chemokine expression and leukocyte migration
into the brain continued beyond the immediate clearance of repli-
cating HSV-1 with acyclovir treatment, with sustained expression
of the chemokines CCL2 and CXCL1 and ongoing migration of in-
flammatory monocytes and neutrophils. Attenuation of CCL2
signaling using Ccr2/ mice resulted in decreased monocyte
recruitment, uncontrolled viral replication, BBB breakdown, and
increased morbidity. Conversely, abrogation of CXCL1 signaling
in Cxcr2/ mice was associated with marked reduction in both
neutrophil recruitment and BBB permeability, along with reduced
morbidity, without substantively altering viral control. Using a
combination of confocal microscopy and in vitro studies, we
demonstrate that CXCL1 is expressed by perivascular astrocytes
in response to HSV-1 infection and by both astrocytes and neu-
rons in response to IL-1a. Using intravital microscopy, we demon-
strate that CXCR2 is required for both neutrophil transmigration
and retention in the abluminal perivascular space and that ex-
travasated neutrophils promote subsequent increased BBB
permeability. Notably, although antibody blockade of CXCL1 ex-
erted a lesser effect on neutrophil arrest thanCxcr2deficiency, the
aCXCL1 antibodywas as effective at inhibiting neutrophil transen-
dothelial migration and abluminal accumulation as Cxcr2 defi-
ciency. These studies identify the CXCL1-CXCR2 axis as a key
promoter of increased BBB permeability in HSV-1 encephalitis.
Altogether, these findings suggest that adjunctive immunomodu-
latory therapy, particularly targeting CXCL1 and neutrophil trans-
endothelial migration, may improve outcomes in HSV-1 encepha-
litis and could have broader implications for viral encephalitis.2 Cell Reports 32, 108150, September 15, 2020RESULTS
HSV-1 Infection Leads to Increased BBB Permeability,
Leukocyte Infiltration, and Morbidity despite Acyclovir
To examine the dissemination of HSV-1 infection in the paren-
chyma following i.c. infection, C57BL/6 mice were anaesthetized
with isoflurane. A sterile Teflon depth-restricted needle was used
to perform i.c. inoculation with 13 105 PFU/mouse or sham infec-
tion with sterile PBS into the subarachnoid space. At day post-
infection (DPI) 1, mice were euthanized and whole-brain tissue
was fixed, frozen, and analyzed by confocal microscopy.
AlthoughHSV-1-infected neuroglia could be identified throughout
the cerebral tissue, there was a predilection for the hippocampus,
which is reflective of human disease (Figure 1A) (Barnett et al.,
1994). To confirm these findings, we repeated the inoculation pro-
cedure with VP26-EGFP-expressing HSV-1 and again identified
that the principal region of virus infection (marked by viral fluores-
cence) was the hippocampus (Figure 1B). To assess the impact of
infection on BBB permeability, C57BL/6 mice received HSV-1 or
sterile PBS i.c. as earlier, and then on DPI 1, mice received an
intravenous (i.v.) injection of Evans blue dye and 30 min later
were sacrificed and perfused to clear intravascular dye. The
appearance of Evans blue in the brain parenchyma andmeninges
was assessed as a measure of BBB permeability. Representative
whole brains demonstrated marked extravasation of Evans blue
dye following HSV-1 infection, reflecting increased BBB perme-
ability (Figure 1C). To confirm these findings, HSV-1- or sham-in-
fectedmice received an i.v. injection of fluorescein isothiocyanate
(FITC)-labeled albumin on DPI 1. After 1 h, whole-brain tissue was
obtained and prepared for confocalmicroscopy. In sham-infected
brain, little extravasated albumin was seen; however, in response
to HSV-1 infection, there was a significant extravasation of albu-
min into the brain parenchyma, around both meninges, and into
the cerebral vasculature (Figures 1D and 1E). Thus, both Evans
blue dye and labeled albumin studies demonstrated increased
BBB permeability following HSV-1 infection.
To determine the impact of antiviral treatment on encephalitis,
sham- and HSV-1-infected mice received a daily dose of either
acyclovir or sterile PBS intraperitoneally (i.p.) starting 24 h
post-infection. In thismodel of acute, severe HSV-1 encephalitis,
there was no significant difference in either morbidity or mortality
following infection between the acyclovir-treated and the un-
treated groups (Figure 1F) despite expedited clearance of repli-
cating HSV-1 by DPI 3 with acyclovir treatment (Figure 1G).
Remarkably, the influx of both neutrophils (CD45hi/CD11b+/Ly6-
Ghi/Ly6Cint) and inflammatory monocytes (CD11b+/CD45hi/
Ly6C+/Ly6G) was observed despite acyclovir treatment and
viral clearance (Figure 1H). Although neutrophil migration was
noted as soon as 6 h post-infection, inflammatory monocytes
did not increase until 24 h post-infection (Figures 1I and 1J); how-
ever, both neutrophil and inflammatory monocyte levels re-
mained consistently elevated at DPI 5 with and without
acyclovir-dependent viral clearance. Flow cytometry of whole
brain was also performed with conjugated antibodies to CD3,
CD4, CD8, and natural killer cells in initial experiments, but
because of the marked predominance of neutrophils and mono-
cytes at these time points, these cell types were not evaluated
further (data not shown).
Figure 1. HSV-1 Infection Leads to Increased BBB Permeability, Leukocyte Transmigration, and Morbidity Despite Acyclovir
(A) Immunohistochemistry was performed on axial sections of brain tissue following i.c. infection with HSV-1 (HSV i.c.) or sham infection with sterile PBS (PBS i.c.)
on DPI 1 (n = 3/group, scale bars: 50 and 200 mm).
(B) Confocal microscopy was performed on axial sections of brain tissue following i.c. HSV-EGFP injection on DPI 1 (n = 3/group, scale bars: 50 and 200 mm).
(C) 24 h following i.c. HSV-1 or sterile PBS injection, mice received Evans blue i.v. 30 min before euthanasia and craniotomy (n = 5/group).
(D and E) 24 h following i.c. HSV or sterile PBS injection, mice received FITC-albumin i.v. 1 h before euthanasia. (D) Immunohistochemistry was performed on axial
sections (n = 4/group, scale bars: 100, 200, and 1,000 mm), and (E) FITC-albumin quantitated and presented as mean ± SD (n = 8/group).
(F)Morbidityscoreandmortalityweredeterminedevery12hfollowing i.c. infectionwithHSV-1usinganestablishedscoringsystempresentedasmean±SEM(n=10/group).
(G) Viral load was determined by plaque assay of whole-brain homogenate (n = 11/group).
(H–J) Gating strategy (H) for flow cytometric analysis of neutrophils andmonocytes recovered fromwhole brains 6–120 h following infection to quantify neutrophil
(Ly6Ghi/Ly6Cint) (I) and inflammatory monocyte (CD11b+/CD45hi) (J) recruitment (n = 6–18/group). Data are presented mean ± SD.
*p < 0.05; **p < 0.01; ***p < 0.001.
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We next examined the production of chemokines and associ-
ated cytokines during the course of infection to assess potential
mediators that might promote migration of these leukocyte
populations. HSV-1- or sham-infected mice again received a
daily dose of either acyclovir or PBS i.p. starting at 24 h post-
infection and were euthanized during the early (DPI 1–3) or late
(DPI 4–5) time points. Whole-brain homogenate was analyzed
by Luminex multiplex assay. Despite acyclovir, significant
upregulation of many CC and CXC chemokines was identified
at both early and late time points, particularly CCL2 and
CXCL1, along with IL-1a (Figures 2A and S1). Chemokine and
cytokine levels remained elevated despite acyclovir treatment,
suggesting that marked viral replication was not necessary for
sustained chemokine expression following HSV-1 infection of
the brain.
To determine the impact of specific chemokine signaling path-
ways on HSV-1 infection and brain inflammation, mice lacking
the cognate receptors for these ligands were studied. First,
Ccr2/ and Cxcr2/ mice were infected i.c. with HSV-1 and
morbidity and mortality were assessed. Ccr2/ mice, which
lack the receptor for CCL2, had a significant increase in
morbidity scores (Figure 2B). In contrast, Cxcr2/ mice, which
lack the receptor for CXCL1, had a less morbid phenotype,
which was particularly evident when morbidity scores were ex-
pressed relative to those of wild-type (WT) mice despite
acyclovir treatment of all groups (Figure 2C). Cxcr2/ mice
also had a trend toward reduced mortality, although Ccr2/
mice showed no significant differences in mortality when
compared with WT mice (Figure 2D).
To determine the impact of abrogation of signaling through
these two chemokine receptors on leukocyte migration, we
studied neutrophils and inflammatory monocytes in Cxcr2/
and Ccr2/ mice infected with HSV-1. On DPI 1, whole-brain
tissue was prepared for flow cytometry immediately post-mor-
tem following intracardiac perfusion to minimize intravascular
cell collection. As anticipated, Cxcr2/ mice had a marked
reduction in neutrophil (CD45hi/CD11b+/Ly6Ghi/Ly6Cint) infiltra-
tion yet retained inflammatory monocyte (CD11b+/CD45hi/
Ly6C+/Ly6G) infiltration (Figure 2E). Conversely, Ccr2/ mice
had a marked reduction in inflammatory monocyte infiltration
with ongoing neutrophil recruitment. Whereas there was no dif-
ference in viral load at DPI 3 between WT and Cxcr2/ mice,
Ccr2/ mice had a dramatic increase in viral load (Figure 2F).
These results suggested that neutrophil infiltration is detrimental
during HSV-1 encephalitis.
To assess the spatial distribution of neutrophils in the HSV-1-
infected brain relative to the resident myeloid-lineage cells, mi-
croglia, we infected CCR2-RFP/CX3CR1-GFP reporter mice
(Saederup et al., 2010) i.c. with HSV-1, and on DPI 1, cerebral
cortex was obtained for whole-mount microscopy. Ex vivo sec-
tions of the frontoparietal cortex were stained with an Ly6G anti-
body, andwe observed that neutrophils (Ly6G+) predominated in
perivascular abluminal spaces, whereas CCR2+ cells were not
seen in the parenchyma in these sections (Figure 2G). Moreover,
to confirm the detrimental effect of neutrophils during HSV-1 en-
cephalitis, we used an anti-Ly6G antibody to deplete neutrophils4 Cell Reports 32, 108150, September 15, 2020on DPI 1, 1, and 3. We observed that when neutrophils were
depleted, there was a significant decrease in mortality and
morbidity during HSV-1 encephalitis (Figure 2H). In addition,
the ratio of the albumin concentration in the brain relative to
the serum of infected mice was determined, reflecting BBB
permeability, which demonstrated a marked reduction in BBB
permeability in Cxcr2/ mice relative to WT HSV-1-infected
mice and, more significantly, to HSV-1-infected Ccr2/ mice
(Figure 2I). Altogether, these results demonstrated that CXCR2
is required for neutrophil migration and increased BBB perme-
ability, which are associated with increased morbidity.
CXCL1 Is Produced by Astrocytes and Neurons
CXCL1 was the predominant CXCR2 ligand upregulated
following HSV-1 infection (Figures 2A and S1). We also noted
that IL-1a, a known activator of neutrophil migration, was upre-
gulated following HSV-1 infection, as has been reported (Bolton
et al., 1998). Therefore, we assessed the impact of the IL-1 re-
ceptor antagonist (IL-1RA) on CXCL1 production in the HSV-1-
infected brain. IL-1RA treatment administered i.p. immediately
following HSV-1 infection was compared with dexamethasone
treatment, which has been previously reported to reduce de-
layed cerebral edema in a murine model of HSV-1 encephalitis
(Meyding-Lamade´ et al., 2003). Mice that received IL-1RA had
a significant reduction in expression of CXCL1 during DPI 1–5
following i.c. HSV-1 infection, which was not seen with dexa-
methasone treatment (Figure 3A). We next examined which glial
populations were associated with CXCL1 production. Following
i.c. HSV-1 infection, whole-brain tissue was prepared on DPI 1
for confocal microscopy. Because astrocytes form an integral
component of the BBB, and because HSV-1 infection is reported
to induce robust expression of cytokines and chemokines bymi-
croglia (Marques et al., 2006), in addition to CXCL1, sections
were stained for GFAP to mark astrocytes, CD11b to identify
microglia, and NeuN to identify neurons, the primary locus of
HSV-1 replication. CXCL1 expression did not co-localize with
CD11b+ microglia but instead co-localized with perivascular
GFAP+ astrocytes and NeuN+ neurons (Figures 3B–3D).
To confirm these observations, we assessed the expression of
CXCL1 and 31 other inflammatory cytokines and chemokines in
the supernatant of cultured primary neurons, microglia, and as-
trocytes following incubation with HSV-1 using the Luminex
multiplex assay. There was marked induction of CXCL1 and
CCL2 protein secretion by astrocytes following incubation with
HSV-1 (Figure 3E). In addition, we evaluated the expression of
IL-1a by neurons, microglia, and astrocytes and found that
only microglia demonstrated induction of IL-1a when incubated
with HSV-1 (Figure 3F). To determine whether CXCL1 production
is the result of paracrine stimulation by IL-1a, we stimulated
cultured primary neurons, microglia, and astrocytes with IL-1a
(10 ng/mL) or control media in vitro and confirmed that both as-
trocytes and neurons, but not microglia, increase CXCL1 pro-
duction after incubation with IL-1a (Figure 3G).This effect was
abrogated by IL-1RA, confirming the results we observed in vivo.
These data support the confocal microscopy data, which identi-
fied CXCL1 expression by neurons and astrocytes during HSV-1
encephalitis in vivo, whereas only astrocytes were demonstrated
to produce CXCL1 in vitro in response to HSV-1 infection.
Figure 2. Cxcr2 Deficiency Reduces Neutrophil Recruitment, BBB Permeability, and Morbidity
(A) Luminexmultiplex protein assay was performed on whole-brain homogenate following i.c. HSV-1 or sterile PBS at early (DPI 1–3) and late (DPI 4–5) time points
and presented as mean ± SEM (n = 4–12/group) in duplicate. See also Figure S1.
(B) Morbidity was determined every 12 h following HSV-1 infection of WT,Ccr2/, andCxcr2/mice treated with acyclovir i.p. daily (n = 10–15/group). Data are
presented as mean ± SEM.
(C) Cumulative morbidity is expressed relative to WT mice and presented as mean ± SEM.
(D) Mortality was assessed twice daily in WT, Ccr2/, and Cxcr2/ mice.
(E) Flow cytometry of whole brain was performed at DPI 3 to quantify neutrophil (Ly6Ghi/Ly6Cint) and inflammatory monocyte (CD11b+/CD45hi) recruitment,
expressed as mean ± SEM (n = 6–10 per group).
(F) Plaque assay of whole-brain homogenate at DPI 3, expressed as mean ± SEM (n = 5–11/group).
(G) Confocal microscopy was performed on brain cortex following infection with HSV-1 in CCR2-RFP/CX3CR1-GFP mice on DPI 1 stained ex vivo for CD31 and
Ly6G to image neutrophil migration, which demonstrated perivascular predominance of Ly6G+ (n = 3, scale bars: 100 and 50 mm).
(H) Mortality and cumulative morbidity after HSV-1 infection was determined with and without neutrophil depletion on DPI 1, 1, and 3. Data are presented as
mean ± SEM.
(I) BBB permeability of WT uninfected mice and HSV-infected WT, Cxcr2/, and Ccr2/mice, shown as mean ± SEM of the brain:serum albumin ratio (n = 3–5/
group).
*p < 0.05; **p < 0.01; ***p < 0.001.
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Abluminal Migratory Behavior
We assessed the impact of CXCL1/CXCR2 expression on the
temporospatial kinetics of neutrophil transendothelial migration
and their intra- and extra-vascular migratory behavior. Neutro-
phils were visualized in LysM-GFP mice that either were WT forCxcr2 or were Cxcr2/. These mice underwent i.c. HSV-1 or
sterile PBS injection, and then cranial window surgery was per-
formed. LysM-GFP is expressed by neutrophils and monocytes;
therefore, mice were imaged 6–8 h following infection during the
early phase of neutrophil migration in response to HSV-1 infec-
tion, as identified in the previous flow-cytometry studies. 6–8 h
post-infection, mice received Qtracker 605 i.v. to delineate bloodCell Reports 32, 108150, September 15, 2020 5
Figure 3. CXCL1 Is Produced by Astrocytes and Neurons
(A) WT mice received IL-1RA or dexamethasone i.p. immediately following HSV-1 i.c. infection, and whole-brain CXCL1 concentration was determined by bead
array during DPI 3–5 (n = 7–19/group in duplicate). Data are presented as mean ± SEM.
(B) Confocal microscopy of HSV-1-infected brain sections was performed at DPI 1 following incubation with GFAP, NeuN, CD11b, and isotype control antibodies
(scale bar: 50 mm).
(C and D) Confocal microscopy of HSV-1-infected (C) and sham-infected (D) brain sections was performed at DPI 1 following incubation with GFAP, NeuN,
CD11b, and CXCL1 antibodies (scale bar: 50 mm).
(E) Primary neurons, microglia, and astrocytes were incubated with HSV-1 for 1 h at a multiplicity of infection (MOI) of 0.1, 1, or 10 or uninfected (UI), and
supernatants collected at 24 h were analyzed by Luminex multiplex array. Data are presented as mean ± SD.
(F) Primary neurons, microglia, and astrocyteswere incubatedwith HSV-1 for 1 h at anMOI of 10 or uninfected (UI), RNAwas extracted, and IL-1aRNA levels were
determined by qRT-PCR and presented as mean ± SD.
(G) Primary neurons, microglia, and astrocytes were stimulated with 10 ng/mL of IL-1a, and CXCL1 production was determined by ELISA. Data are presented as
mean ± SD.
*p < 0.05; **p < 0.01; ***p < 0.001.
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custom imaging stage. In sham-PBS-infected LysM-GFP mice,
LysM-GFP+ neutrophils remained predominantly in the intravas-6 Cell Reports 32, 108150, September 15, 2020cular space (Figure 4A; Video S1). Following i.c. HSV-1 infection,
there was marked transendothelial migration of LysM-GFP+
cells through post-capillary venules that was associated both
Figure 4. The CXCL1-CXCR2 Axis Is Required for Neutrophil Transmigration and Influences Intra-luminal and Abluminal Migratory Behavior
(A–D) Representative images from supplemental videos. (A) Video S1. LysM-GFP mice were imaged using two-photon intravital microscopy immediately
following i.v. injection with Qtracker 605, 6–8 h following infection (n = 3/group). Following sterile PBS i.c., minimal intravascular recruitment and extravasation of
GFP+ neutrophils were seen. (B) Video S2. LysM-GFPmice following i.c. infection with HSV 13 105 PFU exhibit dramatic extravasation of LysM-GFP neutrophils
into the brain, with neutrophils displaying swarming and accumulation in the abluminal space. (C) Video S3. Cxcr2/LysM-GFP mice infected with HSV show
marked recruitment of GFP+ neutrophils to the intravascular space but a striking restriction of extravasation. (D) Video S4. Similarly, in LysM-GFP mice that
received an aCXCL1 antibody following HSV-1 infection, GFP+ neutrophils are inhibited from significant extravasation.
(E) Baseline Qtracker 605 fluorescence was used to compute the vessel surface and intravascular dynamics determined using Imaris. In the intravascular space,
GFP+ neutrophils in Cxcr2/ mice demonstrated significantly longer tracks of greater displacement, with greater mean and minimum speeds and fewer
achieving arrest in comparison to WT mice following HSV-1 infection. Data are presented as mean ± SEM.
(F) In the extravascular space, neutrophils in WT mice demonstrated shorter track lengths and decreased distance from their origin, which was associated with
slower mean and minimum speeds in comparison to neutrophils in Cxcr2/mice, reflecting the predilection for most transmigrated neutrophils to be retained in
the perivascular abluminal region in WT mice, but not Cxcr2/ mice. Data are presented as mean ± SEM.
*p < 0.05; **p < 0.01; ***p < 0.001.
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neutrophils in the perivascular abluminal space (Figure 4B; Video
S2). However, this behavior depended on CXCR2 expression.
Thus, in Cxcr2/LysM-GFP mice infected with HSV-1, GFP+
cells were almost exclusively restricted to the intravascular
space, with few achieving transendothelial migration (Figure 4C;
Video S3). Similarly, blocking CXCR2-CXCL1 interaction with an
aCXCL1 antibody at 2 h after infection reduced neutrophil trans-
endothelial migration (Figure 4D; Video S4). Mice lacking the
leukotriene B4 receptor, BLT1, or the complement C5a receptor,
C5aR1, which are associated with neutrophil migration andswarming (Miyabe et al., 2017; Kim et al., 2006; La¨mmermann
et al., 2013), were studied, but the marked differences in neutro-
phil transendothelial migration seen in Cxcr2/ mice were not
observed in these two mouse strains (data not shown).
To analyze the migratory behavior of LysM-GFP+ neutrophils
in the intravascular and extravascular spaces, the Qtracker
signal was used to compute the vessel surface using Imaris
and the spatiotemporal dynamics of GFP+ cells within and
outside of the vessel surface were compared, respectively. In
the intravascular space, neutrophils in Cxcr2/ mice demon-
strated significantly longer tracks of greater displacement, withCell Reports 32, 108150, September 15, 2020 7
Figure 5. Abrogation of the CXCL1-CXCR2 Axis Reduces BBB Permeability
(A and B) Representative images from supplemental videos (n = 3/group). (A) Video S5. 6–8 h following sterile PBS i.c. injection into LysM-GFP mice. (B) Videos
S6, S7, and S8. Following HSV-1 i.c. infection into LysM-GFP mice, extensive leakage of Qtracker 605 can be seen, reflecting BBB permeability (Video S6),
(legend continued on next page)
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comparison toWTmice following i.c. HSV-1 infection (Figure 4E).
In the extravascular space, transmigrated neutrophils inWTmice
demonstrated reduced distance from their origin, which was
associated with slower mean and minimum speeds in compari-
son to neutrophils in Cxcr2/mice (Figure 4F). This reflected the
predilection for most transmigrated neutrophils to be retained in
the perivascular abluminal region in WT mice, but not Cxcr2/
mice, during early disease.
Abrogation of the CXCL1-CXCR2 Axis Reduces BBB
Permeability
To assess the impact of this altered migratory behavior on BBB
permeability, the volume of extravascular Qtracker 605 leakage
was visualized. To determine the vessel surface, the baseline
Qtracker 605 signal was computed to create a surface using
Imaris. In sham-infected WT mice, minimal Qtracker leakage
was seen (Figure 5A; Video S5). However, following i.c. HSV-1
infection, marked Qtracker leakage was seen, indicating an in-
crease in BBB permeability (Figure 5B; Video S6). Interestingly,
in Cxcr2/ mice and WT mice treated i.v. with aCXCL1, HSV-1
infection was not associated with Qtracker leakage (Figure 5B;
Videos S7 and S8). For quantitative analysis, again the baseline
Qtracker signal was used to establish the vessel surface, and
the volume of Qtracker outside of the computed vessel surface
was measured in voxels to quantify BBB permeability. The ex-
travasated Qdot voxels were quantified for sham-infected WT,
HSV-infected WT, and HSV-infected Cxcr2/ mice and for
HSV-infectedWTmice treatedwith aCXCL1antibody (Figure 5C).
We observed that as previously shown (Figures 1C–1E and 2I),
HSV-1 infection led to increased BBB permeability; however,
the integrity of the BBB was not compromised during infection
of Cxcr2/ mice or in WT mice treated with aCXCL1 antibody.
To determine the impact of CXCR2 and CXCL1 on neutrophil
extravasation, the number of LysM-GFP+ cells was determined
within and outside of the computed vessel surface at each
time point using Imaris. Following i.c. HSV-1 infection, there
was both an increase in intravascular GFP+ neutrophil recruit-
ment and amarked increase in extravascular GFP+ cell accumu-
lation in WT mice (Figure 5D). However, in Cxcr2/LysM-GFP
mice, the converse was seen, with a dramatic reduction in extra-
vascular GFP+ neutrophils and a relative increase in GFP+ cells
restricted to the intravascular space. Similarly, fewer extrava-whereas in Cxcr2/LysM-GFP mice, HSV-1 infection does not induce Qtracker 6
mice 2 h following infection abrogates Qtracker 605 leakage (Video S8).
(C) Volume of Qtracker leakage outside of the vessel surface was determined a
Cxcr2/LysM-GFP mice and in LysM-GFP mice following i.v. aCXCL1. Data sh
(D) Total number of LysM-GFP+ neutrophils in the intravascular and extravasc
computed vessel surface, respectively.
(E) These data are expressed as the intravascular:extravascular ratio, demonstra
GFP mice and in LysM-GFP mice following i.v. aCXCL1.
(F–H) Number of intravascular GFP+ cells that were (F) slow rolling, (G) arrested, or
GFP+ cell arrest in Cxcr2/LysM-GFP mice and to a lesser extent in LysM-GFP
rolling and crawling in Cxcr2/ mice.
(I and J) Slow rolling, arrest, crawling, new extravasation, and abluminal numbers
leakage (red) over time, demonstrating that only the number of abluminal GFP+
(K) Film strip image from Video S9, demonstrating perivascular crawling of an ext
leakage (white arrow).
All data in this figure are presented as mean ± SEM. *p < 0.05; **p < 0.01; ***p <sated GFP+ cells were identified in WT mice treated with
aCXCL1 relative to the intravascular cells. To more accurately
quantitate the relative extravasation between the groups, the
intravascular-to-extravascular LysM-GFP ratio was calculated.
These analyses showed a significant reduction in the proportion
of extravasated LysM-GFP+ neutrophils in both Cxcr2/ mice
and aCXCL1 antibody-treated WT mice (Figure 5E).
To interrogate the specific phases of migration that best corre-
lated with BBB breakdown, the number of LysM-GFP+ neutro-
phils that exhibited slow rolling, arrest, and crawling at each
time point was determined (Phillipson et al., 2009). In compari-
son to sham infection with sterile PBS, HSV-1 infection was
associated with an increase in the number of neutrophils at
each stage of migration (Figures 5F–5H). However, in Cxcr2/
mice, there was a reduction in the number that achieved arrest
and a corresponding increase in the number of slow rolling
GFP+ neutrophils. In addition, there was an increased number
of GFP+ neutrophils crawling within the blood vessel lumen at
each time point inCxcr2/mice, reflecting impaired transendo-
thelial migration (Figure 5H). The i.v. injection of aCXCL1, 2 h
following infection, in WT mice did not significantly change the
number of slow rolling cells (Figure 5F) and was associated
with amoremodest reduction in the number of GFP+ neutrophils
that arrested than was observed in Cxcr2/ mice (Figure 5G).
Altogether, these data suggest that neutrophil CXCR2 expres-
sion is required for both arrest and transendothelial migration
and that reduced numbers of neutrophils seen achieving arrest
results in correspondingly greater numbers observed slow roll-
ing. In addition, of the limited number of neutrophils that arrest,
a greater number are seen crawling because of impaired trans-
endothelial migration. Finally, treatment with an aCXCL1 anti-
body also partially reduced neutrophil arrest, although not to
the same extent as Cxcr2 deficiency, whereas the aCXCL1 anti-
body was as effective at inhibiting neutrophil transendothelial
migration as Cxcr2 deficiency. These data suggest that although
CXCL1 has a non-redundant function in arrest in this model,
other CXCR2 ligands likely contribute to arrest. Nevertheless,
CXCL1 is themain CXCR2 ligand required for neutrophil transen-
dothelial migration.
Progressive Qtracker leakage over time was analyzed in
LysM-GFP mice in comparison to neutrophil slow rolling, arrest,
crawling, new extravasation, and total abluminal cell count over
time. Of these parameters, only the total number of abluminal05 leakage (Video S7). Similarly, administration of i.v. aCXCL1 into LysM-GFP
t each time point, confirming significant amelioration of BBB permeability in
own are representative of 3 independent experiments.
ular spaces was determined by calculating those within and outside of the
ting marked reduction in extravasation of GFP+ neutrophils in Cxcr2/LysM-
(H) crawling at each time point was computed by Imaris, showing a reduction in
mice following i.v. aCXCL1 and a relative increase in the number of cells slow
of GFP+ cells (blue) in LysM-GFPmice were expressed relative to Qtracker 605
cells correlated with BBB permeability.
ravasated LysM-GFP+ neutrophil (yellow arrow) and subsequent Qtracker 605
0.001; ****p < 0.0001.
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ability over time (Figure 5I), and this directly correlated with
Qtracker leakage at any time point (Figure 5J). This suggested
that neutrophil transmigration was temporally and spatially asso-
ciated with BBB permeability. The latter process was visualized
in a representative movie of three experiments during which an
extravasated neutrophil was monitored and demonstrated ablu-
minal crawling before Qtracker leakage, suggesting that the
presence of transmigrated neutrophils in the perivascular space
can directly increase BBB permeability (Figure 5K; Video S9).
DISCUSSION
Our work demonstrates that following i.c. infection with HSV-1,
the virus localized to the hippocampus and was accompanied
by a cascade of chemokines, particularly CXCL1 and CCL2,
that drove the migration of neutrophils and inflammatory mono-
cytes into the brain, respectively. Remarkably, the migration of
these innate immune cells continued despite the enhanced
clearance of virus with acyclovir. We have found that abrogation
of CCL2-CCR2 signaling was associated with diminished mono-
cyte recruitment, increased viral load, and increased morbidity.
Conversely, abrogation of CXCL1-CXCR2 signaling was associ-
ated with diminished neutrophil migration into the brain,
decreased BBB permeability, and reduced morbidity but did
not significantly alter viral load. Using intravital microscopy, we
demonstrated that HSV-1 infection led to transmigration of
neutrophils and perivascular swarming, which depended on
CXCL1-CXCR2 signaling. CXCL1 was produced by perivascular
astrocytes in response to HSV-1 and by both astrocytes and
neurons in response to microglia-derived IL-1a. Abrogation of
this chemokine pathway attenuated neutrophil arrest, transmi-
gration, and the breakdown of the BBB. Specifically, CXCL1 ex-
erted a modest effect on neutrophil arrest but was critical for the
transendothelial migration and abluminal accumulation of neu-
trophils, which correlated with increased BBBpermeability. Alto-
gether, these results argue that despite acyclovir treatment, the
recruitment of CCR2+ inflammatory monocytes is critical for the
control of HSV-1, whereas CXCR2+ neutrophil transmigration is
not required for the control of viral replication and contributes
to the immunopathogenesis of the condition.
A previous study used corneal scarification to inoculate HSV-1
and observed that the administration of acyclovir from 24 h
following detection of virus in the central nervous system
(CNS) did not reduce either mortality or CD45hi inflammatory
infiltrate (Lundberg et al., 2008). During localized corneal infec-
tion with HSV-1, neutrophil migration and keratitis were reduced
following administration of anti-CXCL1monoclonal antibody and
inCxcr2/mice (West et al., 2014); however, the role of CXCL1-
CXCR2 in the CNS response to HSV-1 infection has been un-
clear. CXCL1 expression in the CNS has also been seen in
response to i.p. lipopolysaccharide injection in mice and to
pneumococcal CNS infection in Wistar rats, which was associ-
ated with breakdown of the BBB (McKimmie and Graham,
2010; Barichello et al., 2012; Roy et al., 2012). However, chemo-
kine expression by specific neuroglial cells, particularly in
response to viral infection, has been less frequently studied.
Dengue virus i.c. infection has been demonstrated to induce10 Cell Reports 32, 108150, September 15, 2020the expression of multiple chemokines and leukocyte adhesion
to endothelium, although the critical receptor-ligand interactions
driving leukocyte transendothelial migration and increased BBB
permeability were not elucidated (Amaral et al., 2011).
We also observed that following infection with HSV-1, CXCL1
expression by neurons and astrocytes, as opposed to microglia,
increased as observed by the co-localization of CXCL1 with
GFAP+ perivascular astrocytes and NeuN+-expressing neurons
in vivo. CXCL1 has not previously been shown to co-localize
with astrocytes following HSV-1 infection, although this has
been reported in response to mouse hepatitis virus infection
and NMDA stimulation of corticostriatal slice cultures (Hosking
et al., 2009; Katayama et al., 2009; Mancini and Vidal, 2018).
Nevertheless, microglia are important resident CNS immune
cells and produce a robust inflammatory cytokine response to
HSV-1 in vitro (Marques et al., 2006). CXCL1 expression has
also been reported to be expressed by activated microglia, peri-
cytes, and endothelial cells in response to non-HSV-1 stimuli
(Marques et al., 2006; Semple et al., 2010; Kim and Luster,
2015). However, astrocytes ensheath most cerebral blood ves-
sels, together with pericytes, forming a critical component of
the BBB and are capable of inflammatory cytokine production
(Liddelow et al., 2017). It has been postulated that transmigrated
leukocytes migrate in response to local chemokine gradients,
and here we have shown that the principle chemokine produced
in response to HSV-1 infection also co-localizes with astrocytes
lining the perivascular space in which transmigrated neutrophils
accumulate (Weninger et al., 2014).
Interestingly, we found that stimulation of neurons and astro-
cytes with IL-1a increased the expression of CXCL1 and that
the administration of IL-1RA resulted in a marked decrease in
CXCL1 production, suggesting that neuronal and astrocytic
CXCL1 expression is IL-1 dependent. IL-1 can be produced by
microglia following recognition of HSV-1 pathogen-associated
molecular patterns by TLR2 and TLR9 (Wuest and Carr, 2008;
Piret and Boivin, 2015; Marques et al., 2004), and we confirmed
that HSV-1 infection increases IL-1a production by microglia. It
has been demonstrated that in vitro stimulation of purified astro-
cytes produce a range of inflammatory mediators in response to
a microglia-derived cytokine cocktail containing IL-1 (Liddelow
et al., 2017). In addition, the production of TLR2-driven inflam-
matory mediators in purified astrocyte cultures depends on the
paracrine expression of IL-1b by microglia in experimental spinal
cord injury (Rubio and Sanz-Rodriguez, 2007; Pineau et al.,
2010; Facci et al., 2014). In addition, the administration of IL-1
in a murine stroke model is associated with upregulation of
several mediators, including CXCL1, increased neutrophil
recruitment, and a greater volume of ischemic injury; conse-
quently, IL-1RA has been explored in clinical trials of stroke.
However, initial evidence of efficacy in murine models of
stroke-induced inflammation have not been borne out in clinical
trials, partly because of the short-term and paracrine actions of
IL-1 (McColl et al., 2007; Smith et al., 2018). Nevertheless, the
therapeutic potential of IL-1 antagonism may be limited by the
importance of IL-1 and tumor necrosis factor alpha (TNF-a)
expression in mitigating viral replication (Sergerie et al., 2007).
Moreover, although delayed post-infection corticosteroid ther-
apy has been associated with reduced cerebral edema in
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tion of CXCL1 when dexamethasone was given acutely during
HSV-1 infection, suggesting that more targeted therapies are
required (Meyding-Lamade´ et al., 2003).
We found that CXCR2 was critical for neutrophil arrest and
transendothelial migration and thatCxcr2/mice demonstrated
reduced BBB permeability during HSV-1 infection. However,
although CXCL1 exerted a moderate effect on neutrophil arrest,
it was crucial for transendothelial migration, which was associ-
ated with breakdown of the BBB. Our results further suggest
that injury to the BBB can occur in association with the presence
of abluminal neutrophil retention. There is growing interest in the
potential of this perivenular space between the astrocyte endfeet
of the glia limitans and the abluminal surface of the vascular
endothelium as an immunological niche (Coles et al., 2017).
Here we demonstrate that extravasated neutrophils accumulate
in this space and, in doing so, they may be contributing to sec-
ondary BBB breakdown, which was abrogated in Cxcr2/
mice or following aCXCL1 (Coles et al., 2017). It has been shown
that CXCR2 is critical for transendothelial migration and survival
of neutrophils in models of immune complex-induced arthritis
and TNF-induced cremaster inflammation (Miyabe et al., 2017,
2019; Girbl et al., 2018). Our data suggest that the relative contri-
bution of CXCR2 ligands may be context dependent, because in
the cremaster model, CXCL1 is required for neutrophil arrest and
CXCL2 is required for transendothelial migration (Girbl et al.,
2018). However, the discrepancy in the relative importance of
CXCL1 on neutrophil transendothelial migration may reflect the
predominant expression of CXCL1 by endothelial cells during
TNF stimulation of cremaster muscle, as opposed to the pre-
dominant extra-luminal expression of CXCL1 by astrocytes
and neurons that, along with endothelial tight junctions in the
CNS, may produce a spatially distinct CXCL1 chemokine
gradient (Kim and Luster, 2015; Filippi, 2019). We speculate
that CXCL1 could still contribute to neutrophil arrest from this
compartment following transport into the blood vessel lumen
by the atypical chemokine receptor ACKR1, as has been demon-
strated in a model of inflammatory arthritis (Miyabe et al., 2019).
Following non-lethal LCMV infection in mice, it was elegantly
demonstrated that neutrophils and monocytes transmigrate to-
ward infected perivascular fibroblasts and that this is associated
with BBB leakage (Kim et al., 2009). Here we identify that the
pivotal chemokine in this process during HSV-1 infection is
CXCL1 and that it is not arrest but both transendothelial migra-
tion and perivascular abluminal accumulation of neutrophils
that are spatially and temporally associated with injury to the
BBB. The exact mechanisms by which abluminal neutrophils
contribute to breakdown of the BBB requires study. However,
transendothelial migration of neutrophils has been associated
with neurotoxicity, release of proteases, loss of tight junction
proteins, and production of neutrophil extracellular traps (Bolton
et al., 1998; Allen et al., 2012; Finsterbusch et al., 2014;Weninger
et al., 2014; de Buhr et al., 2017). In addition, in vivo models of
ischemia/reperfusion injury have identified that post-migration
neutrophil elastase production plays a vital role in remodeling
of the venular basement membrane (Voisin et al., 2019). In addi-
tion, transmigrated neutrophils demonstrate upregulated
expression of CXCL2 and CCL2, suggesting that the abluminalpresence of perivascular neutrophils may perpetuate additional
neutrophil and monocyte transendothelial migration, with the
possibility of vicious neutrophil-monocyte crosstalk that leads
to increased neuronal and BBB damage (Chou et al., 2010; Li
et al., 2016; Soehnlein et al., 2017; Weninger et al., 2014). It
seems likely that the relative contribution of CXCR2 signaling
to neuropathology and mortality depends on the primary popu-
lation of infected cells and the chronology of infection. For
example, in West Nile virus encephalitis, CXCR2+ neutrophils
serve as a reservoir for early viral dissemination into the CNS
but are later required for effective viral clearance (Bai et al.,
2010; Wang et al., 2012), whereas HSV-1, along with many other
viruses causing encephalitis, does not require neutrophils for
migration into the CNS and instead establishes CNS infection
following neuronal transportation (Smith et al., 2001). Neutrophil
swarming behavior has been reported in several organs,
including lymph nodes, lung, and skin, in response to bacterial
or parasite infection. Here we identified perivascular neutrophil
swarming in response to viral infection in the brain in regions of
increased BBB permeability, potentially reflecting remodeling
of the extravascular matrix (Kienle and La¨mmermann, 2016).
Nevertheless, the impact of neutrophil migration appears to be
context dependent, because an inducible astrocyte-specific
CXCL1 transgenic model resulted in increased neutrophil migra-
tion, which was associated with demyelination, but not a break-
down of the BBB (Marro et al., 2016; Grist et al., 2018). In
contrast, in a transgenic model of oligodendrocyte-specific
CXCL1 constitutive expression, neutrophil infiltration into the
brain was associated with disruption of the BBB and increased
mortality without dysmyelination (Tani et al., 1996).
Neutrophil depletion before i.c. infection with the neurotropic
JHM strain of mouse hepatitis virus has been associated with
reduced BBB permeability in a mouse model, although recep-
tor/ligand interactions and migratory dynamics were not estab-
lished (Zhou et al., 2003). Similarly, depletion of neutrophils in a
model of experimental autoimmune myelitis has been associated
with reduced spinal cord BBB compromise, and IL-1r1/ mice
exhibited reduced neutrophil arrest (Carlson et al., 2008; Aube´
et al., 2014). Here we identify that CXCL1 is the major CXCR2
ligand upregulated in the brain during HSV-1 encephalitis, can
be inhibited by IL-1RA, and is critical for the neutrophil transendo-
thelial migration and abluminal accumulation, which correlates
withBBBpermeability. aCXCL1 antibody treatment only exhibited
a partial effect on neutrophil arrest relative to CXCR2 deficiency,
which may reflect a role for additional CXCR2 ligands in arrest,
suchasCXCL2, ormay reflect a difference in efficacy between ge-
netic deficiency and antibody-mediated inhibition.
Overall, our work demonstrates that during HSV-1 encephali-
tis, despite viral clearance with acyclovir, IL-1-dependent
CXCL1 production from perivascular astrocytes and neurons
plays a pivotal role in the CXCR2-dependent transendothelial
migration of neutrophils into the brain and their accumulation in
the abluminal space. These recruited neutrophils are likely key
drivers of increased BBB permeability, which is associated
with increased morbidity and mortality. Thus, blockade of the
CXCL1-CXCR2 chemokine axis could be a therapeutic
approach to attenuate CNS injury in HSV-1 encephalitis by inhib-
iting neutrophil recruitment into the brain.Cell Reports 32, 108150, September 15, 2020 11
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Antibodies
TruStain fcX anti-mouse CD16/32 (Clone 93) Biolegend Cat# 101320, RIID:AB_1574973
APC-conjugated CD45 (Clone 30-F11) Biolegend Cat#103112, RRID:AB_312977
PE-conjugated CD11b (Clone M1/70) Biolegend Cat# 101208, RRID:AB_312791
BV605-conjugated CD11c (Clone N418) Biolegend Cat# 117334, RRID:AB_2562415
BV421-conjugated Ly6G (Clone 1A8) BD Biosciences Cat# 562737, RRID:AB_2737756
FITC-conjugated Ly6C (Clone AL-21) BD Biosciences Cat# 553104, RRID:AB_394628
AF647-conjugated CD31 (Clone 390) Biolegend Cat# 102415, RRID:AB_493411
PE-conjugated CD31 (Clone 390) Biolegend Cat# 102408, RRID:AB_312903
APC-conjugated Ly6G (Clone 1A8) Biolegend Cat# 127613, RRID:AB_1877163
eFluor 780-conjugated viability dye ThermoFisher Scientific Cat# 65-0865-14
rabbit polyclonal anti-CXCL1-AF555 Bioss Cat# bs-10234R-AF555
rabbit polyclonal IgG2b isotype control Bioss Cat# bs-0295P-AF555
FITC-conjugated NeuN Abcam Cat# ab223994
Pacific Blue-conjugated CD11b (Clone M1/70) Biolegend Cat# 101223, RRID:AB_755985
APC-conjugated GFAP (Clone S206A-8) Sigma Cat# SAB5201114, RRID:AB_2827276
Albumin–fluorescein isothiocyanate conjugate
(FITC-Albumin)
Sigma Cat# A9771
InVivoMab anti-mouse Ly6G (Clone 1A8) Bxcell Cat# BE0075-1, RRID:AB_1107721
InVivoMab rat IgG2a isotype control (Clone 2A3) Bxcell Cat# BE0089, RRID:AB_1107769
Bacterial and Virus Strains
HSV-1-KOS David Knipe (Harvard Medical School) Colgrove et al., 2016
VP26-eGFP-HSV-1 David Knipe (Harvard Medical School) Desai et al., 1998
Chemicals, Peptides, and Recombinant Proteins
Phosphate-Buffered Saline Sigma Cat# P-4417
Acyclovir Tocris Cat# 2513/50
Evans Blue Sigma Cat# E2129-10G
Xylazine Patterson Veterinary Cat# 78081939
Ketamine Patterson Veterinary Cat# 78908590
Triton X-100 Sigma Cat# 11332481001
IL1RA, Kineret (Anakinra) Sobi, Inc
Fetal Bovine Serum Sigma Cat# F2442
L-Glutamine Sigma Cat# G7513
Glutamax Fisher Scientific Cat# 35-050-061
HEPES Corning Cat# 25-060-CI
Penicillin/Streptomycin Lonza Cat# 17-602E
IgG Human Serum Sigma Cat# I4506, RRID:AB_1163606
Percoll GE Life Sciences Cat# 17089102
Serum-Free Protein Block Agilent Cat# X090930-2
Antibody diluent Agilent Cat# S080981-2
ProLong Diamond Antifade Mountant with DAPI Thermo Fisher Scientific Cat# P36962
ProLong Diamond Antifade Mountant Thermo Fisher Scientific Cat# P36961
UltraComp eBeads eBioscience Cat# 01-2222-41
CountBrightTM counting beads Thermo Fisher Scientific Cat# C36950
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Xylocaine 2% AAP Pharmaceuticals Cat# 43323049231
Qdot-605 Thermo Fisher Scientific Cat# Q25021MP
MultiScribe Reverse Transcriptase Thermo Fisher Scientific Cat# 4311235
TRIzolTM Reagent Thermo Fisher Scientific Cat# 15596026
Critical Commercial Assays
Cytometric Bead Array EMD Millpore Cat# MCYTMAG-70K-PX32
Mouse Albumin ELISA Kit Abcam Cat# ab108791
QuantiFast SYBR Green RT-PCR Kit (400) Qiagen Cat # 204154
Primary Neurons from CD1 mice ScienCell Research Cat# M1520
Microglia from CD1 mice ScienCell Research Cat# M1900
Astrocytes from CD1 mice ScienCell Research Cat# M1820
Poly-L-Lysine, 1 mg/ml ScienCell Research Cat# 0403
Neuronal medium ScienCell Research Cat# 1521
Microglia medium ScienCell Research Cat# 1901
Astrocyte medium ScienCell Research Cat# 1831
Vero cells Thorsten Mempel (Massachusetts General
Hospital)
DMEM Corning Cat# 15-013-CV
Experimental Models: Organisms/Strains
Mouse: C57BL/6 Charles River Laboratories Cat# 556
Mouse: C57BL/6-CCR2-/- Jackson Laboratory Cat# 17586
Mouse: C57BL/6-CXCR2-/- Jackson Laboratory Cat# 6848
Mouse: C57BL/6-LysM-GFP Thomas Graf (Albert Einstein College
of Medicine)
Faust et al., 2000
Mouse: C57BL/6-CCR2-RFP/CX3CR1-GFP Joseph El Khoury (Massachusetts
General Hospital)
Parent strains 005582 and 017586,
Saederup et al., 2010
Oligonucleotides
IL-1a Forward: 5’-TCTATGATGCAAGCTATGG
CTCA-3’
Integrated DNA Technologies
IL-1a Reverse: 5’-CGGCTCTCCTTGAAGGTGA-3’ Integrated DNA Technologies
Software and Algorithms
FlowJo TreeStar Inc. V10.6.1
Zen Zeiss Oberkochen, Germany
Prism 8 Graphpad N/A
ImageJ National Institutes of Health (NIH) Rueden et al., 2017
Imaris Bitplane
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Luster (aluster@mgh.harvard.edu).
Materials availability
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HSV strains
HSV-1-KOS (Colgrove et al., 2016) and VP26-eGFP-HSV-1 (Desai et al., 1998) were kindly provided by D.M. Knipe (Harvard Medical
School) and prepared and titrated using Vero cells grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
fetal calf serum, 1% HEPES, 1% GlutaMAX, penicillin G, and streptomycin (Brockman and Knipe, 2002).
Mice and infection model
Approval for the study was obtained from the Partners Healthcare Institutional Animal Care and Use Committee. C57BL/6 female
mice were obtained from Charles River Laboratories. Ccr2/ (Si et al., 2010), Cxcr2/ (Cacalano et al., 1994) and LysM-GFP
mice (Faust et al., 2000) in the C57BL/6 background were maintained in our mouse colony. Cxcr2/LysM-GFP were generated
in house by breeding Cxcr2/ and LysM-GFP mice. CCR2-RFP/CX3CR1-GFP mice (Saederup et al., 2010) were kindly supplied
by J. El Khoury (Massachusetts General Hospital). Mice used for the experiments were females aged 8-14 weeks. Mice were
aged 12-14 weeks for intravital microscopy studies to ensure sufficiently robust ossification of cranial sutures thereby limiting cere-
bral trauma during craniotomy surgery. Mice were anaesthetized with isoflurane and underwent intracranial infection using a Teflon-
depth-restricted fine-bore needle (BD Biosciences and Sigma Aldrich), through the sagittal suture with either 20uL of HSV-KOS
1x104-5 in PBS or sham infection with sterile PBS into the subarachnoid space (Kurt-Jones et al., 2004). Acyclovir (Tocris) was recon-
stituted in sterile PBS and injected intraperitoneally (50mg/kg) daily commencing 24hours after i.c. infection. Acyclovir was admin-
istered in all the experiments using Ccr2/ and Cxcr2/ mice in order to reflect clinical disease management in humans.
Primary cell cultures
Primary neurons, microglia, and astrocytes isolated from CD1 mice were obtained from ScienCell Research Laboratories (Carlsbad,
CA). Neurons and microglia were seeded onto 24 well cell culture plates coated with Poly-L-Lysine (10 mg/ml) (ScienCell Research
Laboratories), while astrocytes were first expanded in a Poly-L-Lysine coated T-75 flask prior to seeding onto Poly-L-Lysine coated
24 well cell culture plates. Neurons, microglia and astrocytes were maintained in neuronal medium, microglia medium, and animal
astrocyte medium (ScienCell Research Laboratories) respectively, until confluent and ready to use.
Cell lines
Vero cells were provided by Thorsten Mempel (Massachusetts General Hospital). The cells weremaintained and sub-cultured in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum, 1% HEPES, 1% GlutaMAX, penicillin G, and
streptomycin (Brockman and Knipe, 2002).
METHOD DETAILS
Neurological Disease Severity score and Evans Blue assessment of BBB permeability
Following infection mice were examined twice daily using an established score of murine neurological morbidity due to HSV-1
encephalitis (Thomas et al., 2001). To visualize BBB permeability, mice were anaesthetized with ketamine/xylazine and injected
intravenously with 100ul of 2% Evans blue in sterile PBS 30 min prior to euthanasia following a modified version of previously estab-
lishedmethodology (Bennett et al., 2010; Shen et al., 2019). Mice were then euthanized with CO2 and death confirmed by transection
of the great arteries. A craniotomy was performed and images taken. For the assessment of BBB permeability using the brain to
serum albumin ratio, a cardiac puncture was performed to extract blood immediately after euthanasia performedwith CO2. The blood
was left to clot for 30min at 4C and centrifuged at 5,000 rpm for 5min to obtain serum. A craniotomywas performed and brains were
homogenized in PBS using a BeadBeater (Biospec) followed by a centrifugation at 15,000 rpm for 5 min. The levels of albumin in
serum and brain was assessed by performing an ELISA on the serum and brain supernatants following the manufacturer’s instruc-
tions (Cat ab108791, Abcam).
Flow cytometry
Leukocytes were isolated from brain samples which were dissociated using GentleMACS and isolated on a discontinuous 70:30 Per-
coll gradient (Gelifesciences). The meninges were not removed from the brain, therefore the leukocyte populations identified reflect
those of the parenchyma and cerebral meninges. Cells were blocked with TruStain fcX anti-mouse CD16/32 antibody (Biolegend,
Clone 93, Cat# 101320, 1:25) and stained with the following primary antibodies: APC-conjugated CD45 antibody (Biolegend, Clone
30-F11, Cat#103112, 1:400), PE-conjugated CD11b antibody (Biolegend, Clone M1/70, Cat# 101208, 1:200), BV605-conjugated
CD11c antibody (Biolegend, Clone N418, Cat# 117334, 1:400), BV421-conjugated Ly6G antibody (BD Biosciences, Clone 1A8,
Cat# 562737, 1:200) and the FITC-conjugated Ly6C antibody (Biolegend, Clone AL-21, Cat# 553104, 1:200).
UltraComp eBeads (eBioscience) were used for compensation and heat-shocked spleenocytes for viability control using eFluor
780-conjugated viability dye (eBioscience). Samples were analyzed on a LSRII (BD Bioscience) with fluorescent CountBrightTM
counting beads (Thermofisher). All data analysis was performed using the flow cytometry analysis program FlowJo (Treestar).Cell Reports 32, 108150, September 15, 2020 e3
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Whole brains were isolated into 1mL sterile PBS and homogenizedwith 1mmglass beads using aBeadBeater (Biospec). The solution
was centrifuged at 15,000 rpm for 5 min and the supernatant collected. Prior to analysis, the supernatants were incubated for 1h at
room temperature with 10% Triton X-100 at a ratio of 20:1 to inactivate the viral particles. Levels of the following 32 cytokines and
chemokines were assessed using a Luminex bead-basedmultiplex assay (MCYTMAG-70K-PX32, EMDMillipore): G-CSF, GM-CSF,
M-CSF, TNF-a, IFN-g, IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17, CXCL1,
CXCL2, CXCL5, CXCL9, CXCL10, LIF, CCL2, CCL3, CCL4, CCL5, CCL11, and VEGF. IL-1RA (Kineret) 10mg/kg or dexamethasone
(Sigma) 8mg/kg was given i.p. immediately following infection.
Plaque assay
Vero cells were seeded on 24 well plates at a concentration of 2.2x105 cells/ml. When 90% confluency was reached, the cells were
incubated for 1h with serially diluted brain homogenate supernatant, isolated as above for the Luminex assay, in serum free DMEM
medium at 37C. The virus was removed by washing the cells with sterile PBS and 1ml of DMEM medium supplemented with FBS,
Pen/strep, L-Glutamine, and human IgG (Sigma Aldrich) was added and the cells were incubated at 37C for 48h (Kurt-Jones et al.,
2004). The infected cells were then fixed and stained with crystal violet, and PFUs were calculated by counting the plaques in the
dilution well containing 10-100 plaques.
Confocal microscopy
Euthanasia was performed with CO2. A post-mortem craniotomy was performed and the whole brain carefully resected, fixed in PLP
for 12 h, then dehydrated using serial sucrose-gradient osmosis. Brains were then embedded in OCT, frozen in 3,4 Methyl Butane,
and stored at 80C. 12 mm sections of organotypic tissue were cut using a crytostat, mounted on glass slides, and blocked for
10 min with serum-free Dako block (Agilent). To study CXCL1 co-localization sections were stained with the following antibodies
prepared in antibody dilutent (# S080981-2 Agilent) in addition to mounting media (# P36970 Thermofisher): rabbit polyclonal
anti-CXCL1-AF555 (# 10234R Bioss 1:100) or rabbit polyclonal IgG2b isotype control (#0295P Bioss 1:100), GFAP-APC
(# SAB5201114 Sigma 1:100), NeuN-FITC (#ab223994 Abcam 1:100) and CD11b-Pacific Blue (#101223 Biolegend 1:100). To study
localization of neutrophils in CCR2-RFP/CX3CR1-GFP infected mice sections were stained with the following antibodies prepared
in antibody dilutent including DAPI nuclear stain (# P36962 Thermofisher): Ly6G-BV421 (# 562737 Biolegend) and CD31-AF647
(# 102415 Biolegend). For the FITC-albumin experiments, mice were anaesthetized with ketamine/xylazine and injected iv with
10 mg of FITC albumin 60 min prior to euthanasia. Stained sections were imaged with unstained and isotype controls using a Zeiss
Confocal Microscope (Zeiss, Oberkochen, Germany). FITC albumin was quantitated by determining the FITC fluorescence across
organotypic brain tissue slices relative to DAPI nuclear signal to adjust for cell count between samples using ImageJ software (Rue-
den et al., 2017).
Wide-field microscopy
Cerebral cortex was dissected from underlying deep white matter, corpus callosum, caudate, and brain stem on DPI 1 into 3mm sec-
tions and placed into PAB (PBS, 1% BSA, and 0.1% sodium azide) on ice. Samples were blocked with Trustain FcX (anti-mouse
CD16/32; Biolegend 10 mg/mL) and incubated with antibodies for 2 hr at 4C: PE-conjugated anti-CD31 (#102408 Biolegend
8 mL), APC-conjugated anti-CD45 (#103112 clone 30-F11 Biolegend 5 mL) or APC-conjugated anti-Ly6G (#127613 Biolegend
5 mL). Samples of stained cortex were thenwashed in PAB, placed on amicroscope slide and imaged using awide-field fluorescence
microscope and monochrome CCD digital camera and analyzed using Zen Blue software (Zeiss, Oberkochen, Germany).
In vitro infection of primary cells
Primary neurons (#M1520), microglia (#M1900) and astrocytes (#M1820) isolated from CD1 mice where purchased from ScienCell
Research Laboratories (Carlsbad, CA). Cells were cultured in 24 well plates; neurons were seeded at a density of 8.3x104cells/
well, while astrocytes and microglia were seeded at a density of 3x104cell/well. Once cells were confluent they were infected with
HSV-1 KOS at a multiplicity of infection (MOI) of 0.1, 1 and 10 for 1h. Following incubation with the virus the cells were washed twice
with PBS and incubated with the appropriate media for an additional 24h. After incubation the supernatant was collected and stored
at 80C for analysis of cytokine and chemokine secretion using the Luminex multiplex assay described above.
Cranial window surgery and multi-photon intravital microscopy
Mice 4-6 hr post-infection were anesthetized by i.p. injection of Ketamine/Xylazine and positioned on a custom stereotactic surgical
stage on a 37C heating pad, and the skull immobilized. Hair in the frontal and parietal regions of the skull was removed using #40
electrical hair clippers and a chemical depilatory agent (Nair). To reduce the risk of wound infections, the skin was cleaned with an
ethyl alcohol solution and surgery performed under aseptic conditions. A bolus of 100uL of 2% Xylocaine (AAP Pharmaceuticals,
LLC) was injected subcutaneously over the vertex of the cranium. After 2–3 min a semicircle of skin was excised from the top of
the skull, and the underlying periosteum scraped off. Using a high-speed air-turbine drill with a burr tip size of 0.8 mm in diameter
(Fine Science Tools), a groove was made to form a circle of approximately 4mm in the parietal bone of the skull. This area was
made thinner by cautious and continuous drilling of the groove until the bone flap became loose. Cold sterile PBSwas applied duringe4 Cell Reports 32, 108150, September 15, 2020
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from the dura mater underneath, leaving the dura intact. After removal of the bone flap, the dura mater was continuously kept moist
with physiological saline. The window was then sealed by adhering a 5mm cover glass to the bone using a histocompatible cyano-
acrylate tissue glue (Elmer’s Products LLC) and powdered dental repair powder (Lang Dental Manufacturing Co. Inc). Themousewas
then injected intravenously with a 5 mLQdots 605 in 100 mL PBS and placed on custom-built microscopy platform for imaging, while
still under anesthesia. Immersol W 2010 immersion medium was placed between the cranial window and the 20x lens, and window
temperature maintained with an objective warmer (Warner).
MP-IVM was performed using Spectra-Physics Insight DS (830) and MaiTai BB (920) lasers on an Olympus MPE-RS microscope
using Olympus FV305-SW acquisition software. The post-capillary venules of the right parietal cortex of mice were imaged over
23 mins with 4 mm optical sections sequentially scanned over 11 z stacks with 1x optical zoom and a 20x lens providing image vol-
umes of 40 mmdepth and 512 mmwidth. Renderedmovies were analyzedwith Imarisª (Bitplane). To determine the vessel surface the
QTracker-605 signal was determined at baseline and a surface computed with Imarisª; LysM-GFP cells identified outside of this
surface were analyzed reflecting extravasated neutrophils and LysM-GFP cells identified within this surface were analyzed reflecting
intravascular neutrophils. The migratory behavior of LsyM-GFP cells was determined and neutrophils were defined as slow rolling,
crawling, or arrested if they exhibited a speed of 10-40, 2-10 or < 2 mm/sec, respectively, as previously determined (Phillipson et al.,
2009). Blood brain barrier permeability was quantified as volume of QTraquer-605 observed outside of the vessel surface. The data
obtained from the multi-photon intravital microscopy were determined by combining data from 3 independent experiments.
Reverse Transcription Quantitative PCR (RT-qPCR)
Total RNA was collected from primary cell cultures using TRIzol reagent (ThermoFisher) according to manufacturer’s protocol,
diluted in RNase-free water, and stored at80C. cDNA was prepared using reverse transcription, and gene expression quantitated
using aRoche Lightcycler 96 Real-Time PCR system and SYBRGreenMasterMix (Roche). Values were calculated relative to Gapdh.
Validated primer pairs were selected from the MGH PrimerBank.
Mouse Primers
IL-1a Forward: 50-TCTATGATGCAAGCTATGGCTCA-30; IL-1a Reverse: 50-CGGCTCTCCTTGAAGGTGA-30.
Neutrophil depletion
Neutrophils were depleted 24h prior to infection and on days 1 and 3 post-infection by injecting i.p. 0.5 mg of anti-mouse Ly6G anti-
body or isotype control (Bxcell).
QUANTIFICATION AND STATISTICAL ANALYSES
Mice were randomly assigned to receive i.c. HSV-1 or PBS injection, and to receive i.p. acyclovir or PBS. For flow cytometric studies,
a sample size of 6 mice/group provided a 90% power to show a mean difference of 1.5 standard deviation (SD) between the groups
(based on a two-sample t test with a 2-sided 5% significance level). Significance testing was performed between two groups by Stu-
dent’s t test when data were normally distributed and when data were not by Wilcoxon rank sum test, and Fisher’s exact test were
appropriate. We used a two-way ANOVA for multiple group data when data were normally distributed and Linear regression for cor-
relation analyses. Sample sizes and statistical information can be found in the figure legends. Data were analyzed using GraphPad
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